UNSPSC 51273933: Dichlorodifluoromethane/trichloroflouromethane

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273933 Dichlorodifluoromethane/trichloroflouromethane is a Commodity code that shows minimal alignment between its nominal chemical scope and recent state and local procurement activity. The three most recent opportunities tagged under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which are chlorofluorocarbon refrigerants or solvents. The code does not reflect what state and local governments are actually buying under this classification.

The source documents activity across Florida, Texas, and a multi-state cooperative purchasing alliance (Minnesota administering the MMCAP framework serving multiple states including Oregon), but the three opportunities represent health and pharmaceutical procurement rather than industrial chemicals or refrigeration supplies. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with a response deadline of July 26, 2026; the Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs; and the Minnesota Department of Administration's MMCAP alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026. The code exhibits little relevant recent activity under its stated scope.